Advertisement
Advertisement

ETON

ETON logo

Eton Pharmaceutcials, Inc. Common Stock

29.96
USD
Sponsored
-0.86
-2.79%
May 14, 16:00 UTC -4
Closed
exchange

After-Market

30.05

+0.09
+0.30%

Eton Pharmaceutcials, Inc. Common Stock Profile

About

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

Info & Links

CEO

Sean E. Brynjelsen

Headquarters

21925 W. FIELD PARKWAY, SUITE 235
DEER PARK, IL 60010, UNITED STATES

Sector

Medical

Auditor

GRANT THORNTON LLP

Share holders

4

Employees

44

Eton Pharmaceutcials, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

822.16M

Enterprise Value

826.78M

Enterprise Value/EBITDA(ttm)

212.21

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

9.25

Price to Book(mrq)

27.79

Price to Cash(ytd)

5.23K

Profitability

Gross Margin(ttm)

54.15%

Operating Margin(ttm)

-0.79%

Profit Margin(ttm)

-6.09%

Return on Equity(ttm)

-2.60%

Return on Invested Capital(ttm)

-8.62%

Return on Assets(ttm)

-0.66%

Income Statement

Revenue(ttm)

79.95M

Revenue Per Share(ttm)

2.93

Gross Profit(ttm)

42.74M

EBITDA(ttm)3

3.90M

Net Income Available to Common(ttm)

-4.60M

Diluted EPS(ttm)

-0.18

Share Statistics

Beta (5Y Monthly)

0.97

52-Week Change

75.51%

S&P 500 52-Week Change

27.30%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

27.28M

Dividend Yield

0.00%

Float4

22.91M

% Held by Insiders

16.03%

% Held by Institutions

27.86%

Balance Sheet

Total Cash(mrq)

25.94M

Total Cash Per Share(mrq)

0.95

Total Debt(mrq)

30.56M

Total Debt/Equity(mrq)

116.84%

Current Ratio(mrq)

1.57%

Quick Ratio(mrq)

1.17%

Book Value Per Share(mrq)

0.97

Cash Flow

Operating Cash Flow Per Share(ytd)

0.39

Free Cash Flow(ytd)

10.19M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement